Plugs were taken from the centre of each colony and placed into 1 ml of PBS in 1.5 ml tubes
Retatrutide is still investigational and not approved by any regulator as of April 2026, so everything below is presented as clinical-trial data, not as medical guidance
J Clin Endocrinol Metab 75:962968 Chin E, Michels K, Bondy CA (1994) Partition of insulin-like growth factor (IGF)-binding sites between the IGF-I and IGF-II receptors and IGF-binding proteins in the human kidney
Nicest people, very comfortable setting
Stage III (72-96 hours) = Maximal stage of hepatotoxicity = Hepatic failure Clinical features Recurrence of systemic symptoms (anorexia, nausea, vomiting, malaise) Emerging signs & symptoms of hepatic failure : Encephalopathy, jaundice, coagulopathy, hypoglycemia, lactic acidosis, shock
& Banerjee, S